523 related articles for article (PubMed ID: 22929808)
1. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
[TBL] [Abstract][Full Text] [Related]
2. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
4. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
[TBL] [Abstract][Full Text] [Related]
6. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
[TBL] [Abstract][Full Text] [Related]
7. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
[TBL] [Abstract][Full Text] [Related]
8. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients.
Zhang Z; Jin B; Zhang JY; Xu B; Wang H; Shi M; Wherry EJ; Lau GK; Wang FS
J Hepatol; 2009 Jun; 50(6):1163-73. PubMed ID: 19395117
[TBL] [Abstract][Full Text] [Related]
9. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.
Boni C; Fisicaro P; Valdatta C; Amadei B; Di Vincenzo P; Giuberti T; Laccabue D; Zerbini A; Cavalli A; Missale G; Bertoletti A; Ferrari C
J Virol; 2007 Apr; 81(8):4215-25. PubMed ID: 17287266
[TBL] [Abstract][Full Text] [Related]
10. Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation.
Bengsch B; Martin B; Thimme R
J Hepatol; 2014 Dec; 61(6):1212-9. PubMed ID: 25016223
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
[TBL] [Abstract][Full Text] [Related]
12. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
[TBL] [Abstract][Full Text] [Related]
13. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
14. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections.
Oliviero B; Cerino A; Varchetta S; Paudice E; Pai S; Ludovisi S; Zaramella M; Michelone G; Pugnale P; Negro F; Barnaba V; Mondelli MU
J Hepatol; 2011 Jul; 55(1):53-60. PubMed ID: 21145853
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
16. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
[TBL] [Abstract][Full Text] [Related]
17. Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.
Mueller M; Spangenberg HC; Kersting N; Altay T; Blum HE; Klenerman P; Thimme R; Semmo N
J Hepatol; 2010 Jun; 52(6):800-11. PubMed ID: 20416967
[TBL] [Abstract][Full Text] [Related]
18. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
Tseng CT; Miskovsky E; Houghton M; Klimpel GR
Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
[TBL] [Abstract][Full Text] [Related]
19. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
Zerbini A; Pilli M; Boni C; Fisicaro P; Penna A; Di Vincenzo P; Giuberti T; Orlandini A; Raffa G; Pollicino T; Raimondo G; Ferrari C; Missale G
Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
